Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer
Status:
Recruiting
Trial end date:
2026-10-31
Target enrollment:
Participant gender:
Summary
This is an investigator-initiated, single-arm, exploratory clinical study.The study
population consisted of treatment naive advanced esophageal squamous cell carcinoma patients.
The purpose of this study was to evaluate the efficacy and safety of immunotherapy combined
with chemotherapy and residual lesions irradiation of esophageal squamous cell carcinoma.